{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:11:01Z","timestamp":1788401461748,"version":"build-2803163510"},"reference-count":198,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T00:00:00Z","timestamp":1725667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003995","name":"Anhui Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2108085MH298"],"award-info":[{"award-number":["2108085MH298"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TropicalMed"],"abstract":"<jats:p>The order Bunyavirales belongs to the class of Ellioviricetes and is classified into fourteen families. Some species of the order Bunyavirales pose potential threats to human health. The continuously increasing research reveals that various viruses within this order achieve immune evasion in the host through suppressing interferon (IFN) response. As the types and nodes of the interferon response pathway are continually updated or enriched, the IFN suppression mechanisms and target points of different virus species within this order are also constantly enriched and exhibit variations. For instance, Puumala virus (PUUV) and Tula virus (TULV) can inhibit IFN response through their functional NSs inhibiting downstream factor IRF3 activity. Nevertheless, the IFN suppression mechanisms of Dabie bandavirus (DBV) and Guertu virus (GTV) are mostly mediated by viral inclusion bodies (IBs) or filamentous structures (FSs). Currently, there are no effective drugs against several viruses belonging to this order that pose significant threats to society and human health. While the discovery, development, and application of antiviral drugs constitute a lengthy process, our focus on key targets in the IFN response suppression process of the virus leads to potential antiviral strategies, which provide references for both basic research and practical applications.<\/jats:p>","DOI":"10.3390\/tropicalmed9090205","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T03:04:18Z","timestamp":1725851058000},"page":"205","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Suppression of Interferon Response and Antiviral Strategies of Bunyaviruses"],"prefix":"10.3390","volume":"9","author":[{"given":"Yingying","family":"He","sequence":"first","affiliation":[{"name":"Institute of Clinical Virology, Department of Infectious Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China"},{"name":"Department of Clinical Medicine, Anhui Medical University, Hefei 230032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Shen","sequence":"additional","affiliation":[{"name":"Institute of Clinical Virology, Department of Infectious Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China"},{"name":"Department of Clinical Medicine, Anhui Medical University, Hefei 230032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohe","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Clinical Virology, Department of Infectious Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China"},{"name":"Department of Clinical Medicine, Anhui Medical University, Hefei 230032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Yin","sequence":"additional","affiliation":[{"name":"Institute of Clinical Virology, Department of Infectious Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China"},{"name":"Department of Clinical Medicine, Anhui Medical University, Hefei 230032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9794-2366","authenticated-orcid":false,"given":"Bingyan","family":"Liu","sequence":"additional","affiliation":[{"name":"Institute of Clinical Virology, Department of Infectious Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhu","sequence":"additional","affiliation":[{"name":"Institute of Clinical Virology, Department of Infectious Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8480-9004","authenticated-orcid":false,"given":"Zhenhua","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Clinical Virology, Department of Infectious Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Boshra, H. (2022). An Overview of the Infectious Cycle of Bunyaviruses. Viruses, 14.","DOI":"10.20944\/preprints202209.0050.v1"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3390\/v1031003","article-title":"Bunyaviruses and the type I interferon system","volume":"1","author":"Elliott","year":"2009","journal-title":"Viruses"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.antiviral.2017.11.019","article-title":"Second International Conference on Crimean-Congo Hemorrhagic Fever","volume":"150","author":"Spengler","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1177\/19418744221077738","article-title":"An Overview of La Crosse Virus Disease","volume":"12","author":"Matthews","year":"2022","journal-title":"Neurohospitalist"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/INF.0b013e3181c08517","article-title":"World arboviruses: The Bunyaviridae","volume":"28","author":"Overturf","year":"2009","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF01310749","article-title":"Pathogenesis of a phleboviral infection (Punta Toro virus) in golden Syrian hamsters","volume":"114","author":"Anderson","year":"1990","journal-title":"Arch. Virol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1128\/JVI.01074-06","article-title":"The S segment of Punta Toro virus (Bunyaviridae, Phlebovirus) is a major determinant of lethality in the Syrian hamster and codes for a type I interferon antagonist","volume":"81","author":"Perrone","year":"2007","journal-title":"J. Virol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1098\/rspb.1957.0048","article-title":"Virus interference. I. The interferon","volume":"147","author":"Isaacs","year":"1957","journal-title":"Proc. R. Soc. Lond. B Biol. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.4049\/jimmunol.2100339","article-title":"B Cell Activation and Plasma Cell Differentiation Are Promoted by IFN-\u03bb in Systemic Lupus Erythematosus","volume":"207","author":"Barnas","year":"2021","journal-title":"J. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cyto.2015.02.007","article-title":"B cells responses and cytokine production are regulated by their immune microenvironment","volume":"74","author":"Vazquez","year":"2015","journal-title":"Cytokine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1002\/eji.200635993","article-title":"Early type I interferon-mediated signals on B cells specifically enhance antiviral humoral responses","volume":"36","author":"Fink","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1189\/jlb.0908560","article-title":"IFN-\u03b1 amplifies human naive B cell TLR-9-mediated activation and Ig production","volume":"86","author":"Giordani","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/CMR.14.4.778-809.2001","article-title":"Antiviral actions of interferons","volume":"14","author":"Samuel","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.antiviral.2017.08.017","article-title":"Evaluation of antiviral effect of type I, II, and III interferons on direct-acting antiviral-resistant hepatitis C virus","volume":"146","author":"Hamana","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jhep.2022.05.023","article-title":"Hepatitis D virus-induced interferon response and administered interferons control cell division-mediated virus spread","volume":"77","author":"Zhang","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s12250-020-00330-2","article-title":"Herpesviruses and the Type III Interferon System","volume":"36","author":"Yin","year":"2021","journal-title":"Virol. Sin."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1089\/jir.2006.26.373","article-title":"IFN-lambda: Novel antiviral cytokines","volume":"26","author":"Ank","year":"2006","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/jir.2011.0077","article-title":"Interferon-\u03b1 as antiviral and antitumor vaccine adjuvants: Mechanisms of action and response signature","volume":"32","author":"Belardelli","year":"2012","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"21045","DOI":"10.3390\/ijms151121045","article-title":"Interferons and their receptors in birds: A comparison of gene structure, phylogenetic analysis, and cross modulation","volume":"15","author":"Zhou","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.coi.2011.07.007","article-title":"IFN-\u03bbs","volume":"23","author":"Kotenko","year":"2011","journal-title":"Curr. Opin. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.immuni.2019.03.025","article-title":"Shared and Distinct Functions of Type I and Type III Interferons","volume":"50","author":"Lazear","year":"2019","journal-title":"Immunity"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4049\/jimmunol.2100707","article-title":"Beyond Good and Evil: Molecular Mechanisms of Type I and III IFN Functions","volume":"208","author":"Dowling","year":"2022","journal-title":"J. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1089\/jir.2014.0021","article-title":"Interferons, signal transduction pathways, and the central nervous system","volume":"34","author":"Nallar","year":"2014","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imr.12101","article-title":"Interferon induction and function at the mucosal surface","volume":"255","author":"Durbin","year":"2013","journal-title":"Immunol. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1128\/JVI.06757-11","article-title":"Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection","volume":"86","author":"Ioannidis","year":"2012","journal-title":"J. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","article-title":"Toll-like receptors and their crosstalk with other innate receptors in infection and immunity","volume":"34","author":"Kawai","year":"2011","journal-title":"Immunity"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/intimm\/dxh186","article-title":"Toll-like receptors in innate immunity","volume":"17","author":"Takeda","year":"2005","journal-title":"Int. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"11770","DOI":"10.1073\/pnas.1203405109","article-title":"LSm14A is a processing body-associated sensor of viral nucleic acids that initiates cellular antiviral response in the early phase of viral infection","volume":"109","author":"Li","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Rahimi-Tesiye, M., Zaersabet, M., Salehiyeh, S., and Jafari, S.Z. (2023). The role of TRIM25 in the occurrence and development of cancers and inflammatory diseases. Biochim. Biophys. Acta Rev. Cancer, 1878.","DOI":"10.1016\/j.bbcan.2023.188954"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/intimm\/dxp017","article-title":"The roles of TLRs, RLRs and NLRs in pathogen recognition","volume":"21","author":"Kawai","year":"2009","journal-title":"Int. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cytogfr.2018.03.007","article-title":"ADAR1 and PKR, interferon stimulated genes with clashing effects on HIV-1 replication","volume":"40","author":"Radetskyy","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e00209-18","DOI":"10.1128\/mSphere.00209-18","article-title":"The Interferon-Induced Exonuclease ISG20 Exerts Antiviral Activity through Upregulation of Type I Interferon Response Proteins","volume":"3","author":"Weiss","year":"2018","journal-title":"mSphere"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Mirzalieva, O., Juncker, M., Schwartzenburg, J., and Desai, S. (2022). ISG15 and ISGylation in Human Diseases. Cells, 11.","DOI":"10.3390\/cells11030538"},{"key":"ref_34","first-page":"51","article-title":"Mechanisms of induction and action of interferons","volume":"71","author":"Content","year":"2009","journal-title":"Verh. K. Acad. Geneeskd. Belg."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"20053","DOI":"10.1074\/jbc.R700006200","article-title":"Type I interferon receptors: Biochemistry and biological functions","volume":"282","author":"Samarajiwa","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/366129a0","article-title":"The protein tyrosine kinase JAK1 complements defects in interferon-\u03b1\/\u03b2 and -\u03b3 signal transduction","volume":"366","author":"Briscoe","year":"1993","journal-title":"Nature"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/1074-7613(95)90012-8","article-title":"Stat recruitment by tyrosine-phosphorylated cytokine receptors: An ordered reversible affinity-driven process","volume":"2","author":"Greenlund","year":"1995","journal-title":"Immunity"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.83391-0","article-title":"Interferons and viruses: An interplay between induction, signalling, antiviral responses and virus countermeasures","volume":"89","author":"Randall","year":"2008","journal-title":"J. Gen. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Negishi, H., Taniguchi, T., and Yanai, H. (2018). The Interferon (IFN) Class of Cytokines and the IFN Regulatory Factor (IRF) Transcription Factor Family. Cold Spring Harb. Perspect. Biol., 10.","DOI":"10.1101\/cshperspect.a028423"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/ni.2915","article-title":"Diverse intracellular pathogens activate type III interferon expression from peroxisomes","volume":"15","author":"Odendall","year":"2014","journal-title":"Nat. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"7749","DOI":"10.1128\/JVI.02438-06","article-title":"Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases","volume":"81","author":"Zhou","year":"2007","journal-title":"J. Virol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"103420","DOI":"10.1016\/j.autrev.2023.103420","article-title":"IFN-\u03b3: An overlooked cytokine in dermatomyositis with anti-MDA5 antibodies","volume":"22","author":"Thuner","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-gamma: An overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1515\/bmc-2018-0007","article-title":"Interferon-gamma (IFN-\u03b3): Exploring its implications in infectious diseases","volume":"9","author":"Kak","year":"2018","journal-title":"Biomol. Concepts"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev.immunol.17.1.189","article-title":"Natural killer cells in antiviral defense: Function and regulation by innate cytokines","volume":"17","author":"Biron","year":"1999","journal-title":"Annu. Rev. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-94-024-0921-5_1","article-title":"Regulation of IFN-\u03b3 Expression","volume":"941","author":"Fenimore","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.cytogfr.2015.07.003","article-title":"Interleukin-12: Functional activities and implications for disease","volume":"26","author":"Zundler","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1128\/JVI.03021-13","article-title":"Hijacking of RIG-I signaling proteins into virus-induced cytoplasmic structures correlates with the inhibition of type I interferon responses","volume":"88","author":"Santiago","year":"2014","journal-title":"J. Virol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"9691","DOI":"10.1074\/jbc.RA120.013973","article-title":"A RIG-I-like receptor directs antiviral responses to a bunyavirus and is antagonized by virus-induced blockade of TRIM25-mediated ubiquitination","volume":"295","author":"Min","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4149\/av_2017_307","article-title":"NSs protein of severe fever with thrombocytopenia syndrome virus suppresses interferon production through different mechanism than Rift Valley fever virus","volume":"61","author":"Zhang","year":"2017","journal-title":"Acta Virol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e00706","DOI":"10.1128\/JVI.00706-18","article-title":"Two Conserved Amino Acids within the NSs of Severe Fever with Thrombocytopenia Syndrome Phlebovirus Are Essential for Anti-Interferon Activity","volume":"92","author":"Moriyama","year":"2018","journal-title":"J. Virol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.micinf.2018.05.007","article-title":"Nonstructural protein of severe fever with thrombocytopenia syndrome phlebovirus targets STAT2 and not STAT1 to inhibit type I interferon-stimulated JAK-STAT signaling","volume":"20","author":"Kitagawa","year":"2018","journal-title":"Microbes Infect."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4049\/jimmunol.1800576","article-title":"Suppression of the IFN-\u03b1 and -\u03b2 Induction through Sequestering IRF7 into Viral Inclusion Bodies by Nonstructural Protein NSs in Severe Fever with Thrombocytopenia Syndrome Bunyavirus Infection","volume":"202","author":"Hong","year":"2019","journal-title":"J. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1128\/JVI.00154-15","article-title":"Disruption of type I interferon signaling by the nonstructural protein of severe fever with thrombocytopenia syndrome virus via the hijacking of STAT2 and STAT1 into inclusion bodies","volume":"89","author":"Ning","year":"2015","journal-title":"J. Virol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"590","DOI":"10.4049\/jimmunol.2100148","article-title":"Nonstructural Protein NSs Hampers Cellular Antiviral Response through LSm14A during Severe Fever with Thrombocytopenia Syndrome Virus Infection","volume":"207","author":"Zhang","year":"2021","journal-title":"J. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1021\/acsinfecdis.9b00492","article-title":"The Nonstructural Protein of Guertu Virus Disrupts Host Defenses by Blocking Antiviral Interferon Induction and Action","volume":"6","author":"Min","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"9503","DOI":"10.1074\/jbc.RA118.006563","article-title":"Heartland virus antagonizes type I and III interferon antiviral signaling by inhibiting phosphorylation and nuclear translocation of STAT2 and STAT1","volume":"294","author":"Feng","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"16722","DOI":"10.1074\/jbc.M117.805127","article-title":"Heartland virus NSs protein disrupts host defenses by blocking the TBK1 kinase-IRF3 transcription factor interaction and signaling required for interferon induction","volume":"292","author":"Ning","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Holzer, B., Bakshi, S., Bridgen, A., and Baron, M.D. (2011). Inhibition of interferon induction and action by the nairovirus Nairobi sheep disease virus\/Ganjam virus. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0028594"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1128\/JVI.01997-12","article-title":"RNA helicase signaling is critical for type I interferon production and protection against Rift Valley fever virus during mucosal challenge","volume":"87","author":"Ermler","year":"2013","journal-title":"J. Virol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"9798","DOI":"10.1128\/JVI.78.18.9798-9806.2004","article-title":"NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription","volume":"78","author":"Billecocq","year":"2004","journal-title":"J. Virol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1128\/JVI.02148-08","article-title":"NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase","volume":"83","author":"Habjan","year":"2009","journal-title":"J. Virol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.antiviral.2013.03.009","article-title":"Post-exposure vaccination with MP-12 lacking NSs protects mice against lethal Rift Valley fever virus challenge","volume":"98","author":"Gowen","year":"2013","journal-title":"Antivir. Res."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Le May, N., Mansuroglu, Z., L\u00e9ger, P., Josse, T., Blot, G., Billecocq, A., Flick, R., Jacob, Y., Bonnefoy, E., and Bouloy, M. (2008). A SAP30 complex inhibits IFN-\u03b2 expression in Rift Valley fever virus infected cells. PLoS Pathog., 4.","DOI":"10.1371\/journal.ppat.0040013"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Ikegami, T., Narayanan, K., Won, S., Kamitani, W., Peters, C.J., and Makino, S. (2009). Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2\u03b1 phosphorylation. PLoS Pathog., 5.","DOI":"10.1371\/journal.ppat.1000287"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"7987","DOI":"10.1128\/JVI.00643-14","article-title":"RIOK3 is an adaptor protein required for IRF3-mediated antiviral type I interferon production","volume":"88","author":"Feng","year":"2014","journal-title":"J. Virol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.celrep.2015.03.027","article-title":"RIOK3-mediated phosphorylation of MDA5 interferes with its assembly and attenuates the innate immune response","volume":"11","author":"Takashima","year":"2015","journal-title":"Cell Rep."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Havranek, K.E., White, L.A., Bisom, T.C., Lanchy, J.-M., and Lodmell, J.S. (2021). The Atypical Kinase RIOK3 Limits RVFV Propagation and Is Regulated by Alternative Splicing. Viruses, 13.","DOI":"10.3390\/v13030367"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e29236","DOI":"10.7554\/eLife.29236","article-title":"Rift Valley fever phlebovirus NSs protein core domain structure suggests molecular basis for nuclear filaments","volume":"6","author":"Barski","year":"2017","journal-title":"eLife"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e01202","DOI":"10.1128\/JVI.01202-18","article-title":"NSs Protein of Sandfly Fever Sicilian Phlebovirus Counteracts Interferon (IFN) Induction by Masking the DNA-Binding Domain of IFN Regulatory Factor 3","volume":"92","author":"Wuerth","year":"2018","journal-title":"J. Virol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Moalem, Y., Malis, Y., Voloshin, K., Dukhovny, A., Hirschberg, K., and Sklan, E.H. (2022). Sandfly Fever Viruses Attenuate the Type I Interferon Response by Targeting the Phosphorylation of JAK-STAT Components. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.865797"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Ito, T., Wuerth, J.D., and Weber, F. (2023). Protection of eIF2B from inhibitory phosphorylated eIF2: A viral strategy to maintain mRNA translation during the PKR-triggered integrated stress response. J. Biol. Chem., 299.","DOI":"10.1016\/j.jbc.2023.105287"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1128\/JVI.00986-08","article-title":"Hantaan virus nucleocapsid protein binds to importin alpha proteins and inhibits tumor necrosis factor alpha-induced activation of nuclear factor kappa B","volume":"83","author":"Taylor","year":"2009","journal-title":"J. Virol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"E86","DOI":"10.1111\/j.1749-6632.2009.05049.x","article-title":"Inhibition of TNF-\u03b1-induced activation of NF-\u03baB by hantavirus nucleocapsid proteins","volume":"1171","author":"Taylor","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1089\/vim.2015.0004","article-title":"Effects of Different Doses of Nucleocapsid Protein from Hantaan Virus A9 Strain on Regulation of Interferon Signaling","volume":"28","author":"Pan","year":"2015","journal-title":"Viral Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.celrep.2019.04.061","article-title":"The Glycoprotein and Nucleocapsid Protein of Hantaviruses Manipulate Autophagy Flux to Restrain Host Innate Immune Responses","volume":"27","author":"Wang","year":"2019","journal-title":"Cell Rep."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Gallo, G., Caignard, G., Badonnel, K., Chevreux, G., Terrier, S., Szemiel, A., Roman-Sosa, G., Binder, F., Gu, Q., and Da Silva Filipe, A. (2021). Interactions of Viral Proteins from Pathogenic and Low or Non-Pathogenic Orthohantaviruses with Human Type I Interferon Signaling. Viruses, 13.","DOI":"10.3390\/v13010140"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"11790","DOI":"10.1128\/JVI.00916-10","article-title":"Antagonism of type I interferon responses by new world hantaviruses","volume":"84","author":"Levine","year":"2010","journal-title":"J. Virol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1002\/jmv.20948","article-title":"Tula and Puumala hantavirus NSs ORFs are functional and the products inhibit activation of the interferon-beta promoter","volume":"79","author":"Kaukinen","year":"2007","journal-title":"J. Med. Virol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.1128\/JVI.77.9.5507-5511.2003","article-title":"Activation of PKR by Bunyamwera virus is independent of the viral interferon antagonist NSs","volume":"77","author":"Streitenfeld","year":"2003","journal-title":"J. Virol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"31471","DOI":"10.1074\/jbc.M400938200","article-title":"Inhibition of RNA polymerase II phosphorylation by a viral interferon antagonist","volume":"279","author":"Thomas","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"11548","DOI":"10.1128\/JVI.01773-12","article-title":"Viperin, MTAP44, and protein kinase R contribute to the interferon-induced inhibition of Bunyamwera Orthobunyavirus replication","volume":"86","author":"Elliott","year":"2012","journal-title":"J. Virol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1074\/jbc.M110.154799","article-title":"Interferon antagonist NSs of La Crosse virus triggers a DNA damage response-like degradation of transcribing RNA polymerase II","volume":"286","author":"Verbruggen","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e02134-19","DOI":"10.1128\/JVI.02134-19","article-title":"Elongin C Contributes to RNA Polymerase II Degradation by the Interferon Antagonist NSs of La Crosse Orthobunyavirus","volume":"94","author":"Schoen","year":"2020","journal-title":"J. Virol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.meegid.2018.02.027","article-title":"Genomic characterization and evolution of Tacaiuma orthobunyavirus (Peribunyaviridae family) isolated in Brazil","volume":"60","author":"Acrani","year":"2018","journal-title":"Infect. Genet. Evol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e02140-17","DOI":"10.1128\/JVI.02140-17","article-title":"Interferon-Stimulated Gene (ISG)-Expression Screening Reveals the Specific Antibunyaviral Activity of ISG20","volume":"92","author":"Feng","year":"2018","journal-title":"J. Virol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"8314","DOI":"10.1128\/JVI.00975-16","article-title":"Biochemical and Structural Insights into the Preference of Nairoviral DeISGylases for Interferon-Stimulated Gene Product 15 Originating from Certain Species","volume":"90","author":"Deaton","year":"2016","journal-title":"J. Virol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1139\/m71-243","article-title":"A comparison of the protective effect against Mengo virus infection in mice of interferons induced by polyI:C and Mengo virus","volume":"17","author":"Campbell","year":"1971","journal-title":"Can. J. Microbiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s40425-019-0568-2","article-title":"Immunotherapeutic effects of intratumoral nanoplexed poly I:C","volume":"7","author":"Aznar","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Tong, J., Zhu, C., Lai, H., Feng, C., and Zhou, D. (2021). Potent Neutralization Antibodies Induced by a Recombinant Trimeric Spike Protein Vaccine Candidate Containing PIKA Adjuvant for COVID-19. Vaccines, 9.","DOI":"10.1101\/2021.02.17.431647"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.vaccine.2015.01.041","article-title":"The respiratory syncytial virus fusion protein formulated with a novel combination adjuvant induces balanced immune responses in lambs with maternal antibodies","volume":"33","author":"Garg","year":"2015","journal-title":"Vaccine"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3727\/096368915X689622","article-title":"Clinical Trials With Mesenchymal Stem Cells: An Update","volume":"25","author":"Squillaro","year":"2016","journal-title":"Cell Transplant."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Raicevic, G., Najar, M., Busser, H., Crompot, E., Bron, D., Toungouz, M., and Lagneaux, L. (2017). Comparison and immunobiological characterization of retinoic acid inducible gene-I-like receptor expression in mesenchymal stromal cells. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-02850-6"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.tips.2020.06.009","article-title":"Mesenchymal Stem Cell Immunomodulation: Mechanisms and Therapeutic Potential","volume":"41","author":"Song","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41392-021-00754-6","article-title":"Mesenchymal stem cell therapy for severe COVID-19","volume":"6","author":"Shi","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_97","first-page":"105","article-title":"Mesenchymal stem cells in the fight against viruses: Face to face with the invisible enemy","volume":"68","author":"Sleem","year":"2020","journal-title":"Curr. Res. Transl. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.14336\/AD.2020.0711","article-title":"Research progress on Mesenchymal Stem Cells (MSCs), Adipose-Derived Mesenchymal Stem Cells (AD-MSCs), Drugs, and Vaccines in Inhibiting COVID-19 Disease","volume":"11","author":"Gentile","year":"2020","journal-title":"Aging Dis."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(06)68852-1","article-title":"Effect of nitazoxanide for treatment of severe rotavirus diarrhoea: Randomised double-blind placebo-controlled trial","volume":"368","author":"Rossignol","year":"2006","journal-title":"Lancet"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1473-3099(14)70717-0","article-title":"Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: A double-blind, randomised, placebo-controlled, phase 2b\/3 trial","volume":"14","author":"Haffizulla","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.isci.2019.07.003","article-title":"The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus","volume":"19","author":"Jasenosky","year":"2019","journal-title":"iScience"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/j.1365-2036.2006.03128.x","article-title":"Nitazoxanide in the treatment of viral gastroenteritis: A randomized double-blind placebo-controlled clinical trial","volume":"24","author":"Rossignol","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e00127-21","DOI":"10.1128\/JVI.00127-21","article-title":"Acitretin and Retinoic Acid Derivatives Inhibit BK Polyomavirus Replication in Primary Human Proximal Renal Tubular Epithelial and Urothelial Cells","volume":"95","author":"Wu","year":"2021","journal-title":"J. Virol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nm.4124","article-title":"Stimulating the RIG-I pathway to kill cells in the latent HIV reservoir following viral reactivation","volume":"22","author":"Li","year":"2016","journal-title":"Nat. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"243","DOI":"10.5021\/ad.2020.32.3.243","article-title":"Treatment of Recalcitrant Viral Warts with Combination Therapy of Systemic Acitretin and Diphenylcyclopropenone Immunotherapy","volume":"32","author":"Shin","year":"2020","journal-title":"Ann. Dermatol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.phymed.2008.07.013","article-title":"The in vitro and in vivo antiviral effects of salidroside from Rhodiola rosea L. against coxsackievirus B3","volume":"16","author":"Wang","year":"2009","journal-title":"Phytomedicine"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1007\/s00705-016-3034-1","article-title":"Salidroside exhibits anti-dengue virus activity by upregulating host innate immune factors","volume":"161","author":"Sharma","year":"2016","journal-title":"Arch. Virol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"15593258211011335","DOI":"10.1177\/15593258211011335","article-title":"Salidroside Protects Against Influenza A Virus-Induced Acute Lung Injury in Mice","volume":"19","author":"Lu","year":"2021","journal-title":"Dose Response"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Zhang, X., Xie, L., Long, J., Xie, Q., Zheng, Y., Liu, K., and Li, X. (2021). Salidroside: A review of its recent advances in synthetic pathways and pharmacological properties. Chem. Biol. Interact., 339.","DOI":"10.1016\/j.cbi.2020.109268"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.leukres.2017.03.010","article-title":"5\u2032-Triphosphate siRNA targeting MDR1 reverses multi-drug resistance and activates RIG-I-induced immune-stimulatory and apoptotic effects against human myeloid leukaemia cells","volume":"58","author":"Li","year":"2017","journal-title":"Leuk. Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/nm.1887","article-title":"5\u2032-Triphosphate-siRNA: Turning gene silencing and Rig-I activation against melanoma","volume":"14","author":"Poeck","year":"2008","journal-title":"Nat. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"10172","DOI":"10.1073\/pnas.0914561107","article-title":"Gold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replication","volume":"107","author":"Chakravarthy","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e00102-19","DOI":"10.1128\/JVI.00102-19","article-title":"RIG-I Activation by a Designer Short RNA Ligand Protects Human Immune Cells against Dengue Virus Infection without Causing Cytotoxicity","volume":"93","author":"Ho","year":"2019","journal-title":"J. Virol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"e20211818","DOI":"10.1084\/jem.20211818","article-title":"A stem-loop RNA RIG-I agonist protects against acute and chronic SARS-CoV-2 infection in mice","volume":"219","author":"Mao","year":"2022","journal-title":"J. Exp. Med."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Goulet, M.-L., Olagnier, D., Xu, Z., Paz, S., Belgnaoui, S.M., Lafferty, E.I., Janelle, V., Arguello, M., Paquet, M., and Ghneim, K. (2013). Systems analysis of a RIG-I agonist inducing broad spectrum inhibition of virus infectivity. PLoS Pathog., 9.","DOI":"10.1371\/annotation\/8fa70b21-32e7-4ed3-b397-ab776b5bbf30"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Franco, E.J., Pires de Mello, C.P., and Brown, A.N. (2021). Antiviral Evaluation of UV-4B and Interferon-Alpha Combination Regimens against Dengue Virus. Viruses, 13.","DOI":"10.3390\/v13050771"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"26496","DOI":"10.18632\/oncotarget.8420","article-title":"Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs","volume":"7","author":"Ranoa","year":"2016","journal-title":"Oncotarget"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1172\/JCI127471","article-title":"cGAS\/STING axis mediates a topoisomerase II inhibitor-induced tumor immunogenicity","volume":"129","author":"Wang","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.4049\/jimmunol.1100040","article-title":"The DNA damage response induces IFN","volume":"187","author":"Gordon","year":"2011","journal-title":"J. Immunol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1158\/1078-0432.CCR-06-2894","article-title":"Doxorubicin directs the accumulation of interleukin-12-induced IFN\u03b3 into tumors for enhancing STAT1 dependent antitumor effect","volume":"13","author":"Zhu","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/onc.2009.356","article-title":"Immunogenic death of colon cancer cells treated with oxaliplatin","volume":"29","author":"Tesniere","year":"2010","journal-title":"Oncogene"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s43593-022-00029-9","article-title":"Viral inactivation by light","volume":"2","author":"Sadraeian","year":"2022","journal-title":"eLight"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/cts.13548","article-title":"DNA methyltransferase inhibitor exposure-response: Challenges and opportunities","volume":"16","author":"Kagan","year":"2023","journal-title":"Clin. Transl. Sci."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1038\/ncponc0355","article-title":"Optimizing therapy with methylation inhibitors in myelodysplastic syndromes: Dose, duration, and patient selection","volume":"2","author":"Issa","year":"2005","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"e1090077","DOI":"10.1080\/2162402X.2015.1090077","article-title":"Pharmacological DNA demethylation: Implications for cancer immunotherapy","volume":"5","author":"Roulois","year":"2016","journal-title":"Oncoimmunology"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"109706","DOI":"10.1016\/j.intimp.2023.109706","article-title":"Lidocaine inhibits influenza a virus replication by up-regulating IFN\u03b14 via TBK1-IRF7 and JNK-AP1 signaling pathways","volume":"115","author":"Liu","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"7334","DOI":"10.1128\/JVI.06867-11","article-title":"Isoflavone agonists of IRF-3 dependent signaling have antiviral activity against RNA viruses","volume":"86","author":"Bedard","year":"2012","journal-title":"J. Virol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jnutbio.2009.04.004","article-title":"Soy isoflavones and virus infections","volume":"20","author":"Andres","year":"2009","journal-title":"J. Nutr. Biochem."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1128\/JVI.02202-15","article-title":"Targeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR Pathway","volume":"90","author":"Pattabhi","year":"2015","journal-title":"J. Virol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1021\/acs.jmedchem.9b01318","article-title":"p97: An Emerging Target for Cancer, Neurodegenerative Diseases, and Viral Infections","volume":"63","author":"Huryn","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.apsb.2021.09.003","article-title":"A targeted covalent inhibitor of p97 with proteome-wide selectivity","volume":"12","author":"Ye","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Chisamore, M.J., Cunningham, M.E., Flores, O., Wilkinson, H.A., and Chen, J.D. (2009). Characterization of a novel small molecule subtype specific estrogen-related receptor alpha antagonist in MCF-7 breast cancer cells. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0005624"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"He, X., Ma, S., Tian, Y., Wei, C., Zhu, Y., Li, F., Zhang, P., Wang, P., Zhang, Y., and Zhong, H. (2017). ERR\u03b1 negatively regulates type I interferon induction by inhibiting TBK1-IRF3 interaction. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006347"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"E5706","DOI":"10.1073\/pnas.1422361112","article-title":"Estrogen-related receptor \u03b1 is required for efficient human cytomegalovirus replication","volume":"111","author":"Hwang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"16659","DOI":"10.1039\/C9RA10697A","article-title":"Exploring the binding mode and thermodynamics of inverse agonists against estrogen-related receptor alpha","volume":"10","author":"Karnati","year":"2020","journal-title":"RSC Adv."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Lynch, C., Zhao, J., Sakamuru, S., Zhang, L., Huang, R., Witt, K.L., Merrick, B.A., Teng, C.T., and Xia, M. (2019). Identification of Compounds That Inhibit Estrogen-Related Receptor Alpha Signaling Using High-Throughput Screening Assays. Molecules, 24.","DOI":"10.3390\/molecules24050841"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.febslet.2009.01.030","article-title":"Kaempferol is an estrogen-related receptor alpha and gamma inverse agonist","volume":"583","author":"Wang","year":"2009","journal-title":"FEBS Lett."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.fitote.2016.04.015","article-title":"Naringenin exerts anti-angiogenic effects in human endothelial cells: Involvement of ERR\u03b1\/VEGF\/KDR signaling pathway","volume":"111","author":"Li","year":"2016","journal-title":"Fitoterapia"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.biopha.2017.07.016","article-title":"A novel compound LingH2-10 inhibits the growth of triple negative breast cancer cells in vitro and in vivo as a selective inverse agonist of estrogen-related receptor \u03b1","volume":"93","author":"Ning","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.bcp.2010.05.024","article-title":"A novel steroidal inhibitor of estrogen-related receptor \u03b1 (ERR\u03b1)","volume":"80","author":"Duellman","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13045-022-01372-7","article-title":"Targeting ERR\u03b1 promotes cytotoxic effects against acute myeloid leukemia through suppressing mitochondrial oxidative phosphorylation","volume":"15","author":"Seo","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/tpj.2016.48","article-title":"Investigation of 7-dehydrocholesterol reductase pathway to elucidate off-target prenatal effects of pharmaceuticals: A systematic review","volume":"16","author":"Boland","year":"2016","journal-title":"Pharmacogenom. J."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41380-021-01074-5","article-title":"Medication effects on developmental sterol biosynthesis","volume":"27","author":"Korade","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1021\/acschemneuro.0c00765","article-title":"Prescription Medications Alter Neuronal and Glial Cholesterol Synthesis","volume":"12","author":"Tallman","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.virs.2023.06.006","article-title":"STING strengthens host anti-hantaviral immunity through an interferon-independent pathway","volume":"38","author":"Wang","year":"2023","journal-title":"Virol. Sin."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1365-2893.2012.01612.x","article-title":"Tamoxifen alleviates hepatitis C virus-induced inhibition of both toll-like receptor 7 and JAK-STAT signalling pathways in PBMCs of infected Egyptian females","volume":"19","author":"Fawzy","year":"2012","journal-title":"J. Viral Hepat."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41392-021-00853-4","article-title":"Tamoxifen and clomiphene inhibit SARS-CoV-2 infection by suppressing viral entry","volume":"6","author":"Zu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Cham, L.B., Friedrich, S.-K., Adomati, T., Bhat, H., Schiller, M., Bergerhausen, M., Hamdan, T., Li, F., Machlah, Y.M., and Ali, M. (2019). Tamoxifen Protects from Vesicular Stomatitis Virus Infection. Pharmaceuticals, 12.","DOI":"10.3390\/ph12040142"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.immuni.2019.11.015","article-title":"Targeting 7-Dehydrocholesterol Reductase Integrates Cholesterol Metabolism and IRF3 Activation to Eliminate Infection","volume":"52","author":"Xiao","year":"2020","journal-title":"Immunity"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/0016-5085(95)90592-8","article-title":"Treatment of the cholesterol biosynthetic defect in Smith-Lemli-Opitz syndrome reproduced in rats by BM 15.766","volume":"109","author":"Xu","year":"1995","journal-title":"Gastroenterology"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.4049\/jimmunol.0902895","article-title":"Enhancement of antiviral immunity by small molecule antagonist of suppressor of cytokine signaling","volume":"185","author":"Ahmed","year":"2010","journal-title":"J. Immunol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.4049\/jimmunol.0900570","article-title":"HSV-1-induced SOCS-1 expression in keratinocytes: Use of a SOCS-1 antagonist to block a novel mechanism of viral immune evasion","volume":"183","author":"Frey","year":"2009","journal-title":"J. Immunol."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Ahmed, C.M., Dabelic, R., Bedoya, S.K., Larkin, J., and Johnson, H.M. (2015). A SOCS1\/3 Antagonist Peptide Protects Mice Against Lethal Infection with Influenza A Virus. Front. Immunol., 6.","DOI":"10.3389\/fimmu.2015.00574"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Johnson, H.M., Lewin, A.S., and Ahmed, C.M. (2020). SOCS, Intrinsic Virulence Factors, and Treatment of COVID-19. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.582102"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.antiviral.2018.07.006","article-title":"The clinically approved MEK inhibitor Trametinib efficiently blocks influenza A virus propagation and cytokine expression","volume":"157","author":"Dudek","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12964-019-0378-7","article-title":"MEK inhibition drives anti-viral defence in RV but not RSV challenged human airway epithelial cells through AKT\/p70S6K\/4E-BP1 signalling","volume":"17","author":"Baturcam","year":"2019","journal-title":"Cell Commun. Signal."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"108234","DOI":"10.1016\/j.pharmthera.2022.108234","article-title":"\u201cRB-reactivator screening\u201d as a novel cell-based assay for discoveries of molecular targeting agents including the first-in-class MEK inhibitor trametinib (trade name: Mekinist)","volume":"236","author":"Sakai","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.virol.2016.07.019","article-title":"Inhibition of influenza A virus matrix and nonstructural gene expression using RNA interference","volume":"497","author":"McMillen","year":"2016","journal-title":"Virology"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2174\/1566523218666180607091311","article-title":"Inhibition of West Nile virus Replication by Bifunctional siRNA Targeting the NS2A and NS5 Conserved Region","volume":"18","author":"Karothia","year":"2018","journal-title":"Curr. Gene Ther."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Shi, X., Zhang, X., Chang, Y., Jiang, B., Deng, R., Wang, A., and Zhang, G. (2016). Nonstructural protein 11 (nsp11) of porcine reproductive and respiratory syndrome virus (PRRSV) promotes PRRSV infection in MARC-145 cells. BMC Vet. Res., 12.","DOI":"10.1186\/s12917-016-0717-5"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.biotechadv.2007.12.002","article-title":"RNA interference: The story of gene silencing in plants and humans","volume":"26","author":"Mahmoodur","year":"2008","journal-title":"Biotechnol. Adv."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Friedrich, M., Pfeifer, G., Binder, S., Aigner, A., Vollmer Barbosa, P., Makert, G.R., Fertey, J., Ulbert, S., Bodem, J., and K\u00f6nig, E.-M. (2022). Selection and Validation of siRNAs Preventing Uptake and Replication of SARS-CoV-2. Front. Bioeng. Biotechnol., 10.","DOI":"10.3389\/fbioe.2022.801870"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.compbiolchem.2017.06.003","article-title":"Tetracyclines as a potential antiviral therapy against Crimean Congo hemorrhagic fever virus: Docking and molecular dynamic studies","volume":"70","author":"Sharifi","year":"2017","journal-title":"Comput. Biol. Chem."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.4103\/pr.pr_30_17","article-title":"Curcumin and Natural Derivatives Inhibit Ebola Viral Proteins: An In silico Approach","volume":"9","author":"Baikerikar","year":"2017","journal-title":"Pharmacogn. Res."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Jennings, M.R., and Parks, R.J. (2020). Curcumin as an Antiviral Agent. Viruses, 12.","DOI":"10.3390\/v12111242"},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Liu, C.-L., Hung, H.-C., Lo, S.-C., Chiang, C.-H., Chen, I.J., Hsu, J.T.A., and Hou, M.-H. (2016). Using mutagenesis to explore conserved residues in the RNA-binding groove of influenza A virus nucleoprotein for antiviral drug development. Sci. Rep., 6.","DOI":"10.1038\/srep21662"},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Terrier, O., Dilly, S., Pizzorno, A., Chalupska, D., Humpolickova, J., Bou\u0159a, E., Berenbaum, F., Quideau, S., Lina, B., and F\u00e8ve, B. (2021). Antiviral Properties of the NSAID Drug Naproxen Targeting the Nucleoprotein of SARS-CoV-2 Coronavirus. Molecules, 26.","DOI":"10.3390\/molecules26092593"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1128\/AAC.02335-12","article-title":"Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus","volume":"57","author":"Lejal","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Kakisaka, M., Sasaki, Y., Yamada, K., Kondoh, Y., Hikono, H., Osada, H., Tomii, K., Saito, T., and Aida, Y. (2015). A Novel Antiviral Target Structure Involved in the RNA Binding, Dimerization, and Nuclear Export Functions of the Influenza A Virus Nucleoprotein. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1005062"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1590\/S1517-83822013005000050","article-title":"In vitro and in vivo inhibition of rabies virus replication by RNA interference","volume":"44","author":"Iamamoto","year":"2013","journal-title":"Braz. J. Microbiol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000491927","article-title":"RNAi Targeting of Human Metapneumovirus P and N Genes Inhibits Viral Growth","volume":"61","author":"Nitschinsk","year":"2018","journal-title":"Intervirology"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.virol.2021.10.002","article-title":"Short-hairpin RNAs delivered by recombinant adeno-associated virus inhibited the replication of influenza A viruses in vitro","volume":"564","author":"Zhang","year":"2021","journal-title":"Virology"},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Teng, D., Obika, S., Ueda, K., and Honda, T. (2019). A Small Interfering RNA Cocktail Targeting the Nucleoprotein and Large Protein Genes Suppresses Borna Disease Virus Infection. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.02781"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"809","DOI":"10.4014\/jmb.1801.01002","article-title":"Development and Characterization of Monoclonal Antibodies against Nucleoprotein for Diagnosis of Influenza A Virus","volume":"28","author":"Phuong","year":"2018","journal-title":"J. Microbiol. Biotechnol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/j.intimp.2011.08.019","article-title":"Antisense oligonucleotides targeting the RNA binding region of the NP gene inhibit replication of highly pathogenic avian influenza virus H5N1","volume":"11","author":"Zhang","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Cao, J., Dong, S., Liu, Y., Zhou, M., Guo, J., Jia, X., Zhang, Y., Hou, Y., Tian, M., and Xiao, G. (2021). Screening and Identification of Lujo Virus Entry Inhibitors from an Food and Drug Administration-Approved Drugs Library. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.793519"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12985-023-02082-3","article-title":"2-Deoxy-D-glucose inhibits lymphocytic choriomeningitis virus propagation by targeting glycoprotein N-glycosylation","volume":"20","author":"Omasta","year":"2023","journal-title":"Virol. J."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Paj\u0105k, B., Zieli\u0144ski, R., Manning, J.T., Matejin, S., Paessler, S., Fokt, I., Emmett, M.R., and Priebe, W. (2022). The Antiviral Effects of 2-Deoxy-D-glucose (2-DG), a Dual D-Glucose and D-Mannose Mimetic, against SARS-CoV-2 and Other Highly Pathogenic Viruses. Molecules, 27.","DOI":"10.3390\/molecules27185928"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41577-020-0288-3","article-title":"RIG-I-like receptors: Their regulation and roles in RNA sensing","volume":"20","author":"Rehwinkel","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13045-023-01405-9","article-title":"Exploiting RIG-I-like receptor pathway for cancer immunotherapy","volume":"16","author":"Jiang","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"9406","DOI":"10.1128\/JVI.00748-16","article-title":"RIG-I-Mediated STING Upregulation Restricts Herpes Simplex Virus 1 Infection","volume":"90","author":"Liu","year":"2016","journal-title":"J. Virol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3892\/etm.2022.11116","article-title":"Lidocaine relieves murine allergic rhinitis by regulating the NF-\u03baB and p38 MAPK pathways","volume":"23","author":"Xiang","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Pilna, H., Hajkova, V., Knitlova, J., Liskova, J., Elsterova, J., and Melkova, Z. (2021). Vaccinia Virus Expressing Interferon Regulatory Factor 3 Induces Higher Protective Immune Responses against Lethal Poxvirus Challenge in Atopic Organism. Viruses, 13.","DOI":"10.3390\/v13101986"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.tips.2019.03.001","article-title":"Targeting SOCS Proteins to Control JAK-STAT Signalling in Disease","volume":"40","author":"Durham","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_185","first-page":"5963","article-title":"In-silico screening and identification of potential drug-like compounds for dengue-associated thrombocytopenia from Carica papaya leaf extracts","volume":"41","author":"Banjan","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"460","DOI":"10.6026\/97320630010460","article-title":"Molecular Docking Based Screening of Plant Flavonoids as Dengue NS1 Inhibitors","volume":"10","author":"Qamar","year":"2014","journal-title":"Bioinformation"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"304ra141","DOI":"10.1126\/scitranslmed.aaa3787","article-title":"Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination","volume":"7","author":"Beatty","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1099\/0022-1317-69-8-2101","article-title":"Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus","volume":"69","author":"Henchal","year":"1988","journal-title":"J. Gen. Virol."},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Lai, Y.-C., Chuang, Y.-C., Liu, C.-C., Ho, T.-S., Lin, Y.-S., Anderson, R., and Yeh, T.-M. (2017). Antibodies against Modified NS1 Wing Domain Peptide Protect against Dengue Virus Infection. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-07308-3"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1016\/S0264-410X(03)00310-4","article-title":"Evaluation of protective efficacy and immune mechanisms of using a non-structural protein NS1 in DNA vaccine against dengue 2 virus in mice","volume":"21","author":"Wu","year":"2003","journal-title":"Vaccine"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1099\/0022-1317-68-3-853","article-title":"Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1","volume":"68","author":"Schlesinger","year":"1987","journal-title":"J. Gen. Virol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3851\/IMP2073","article-title":"Pathogenic effects of Rift Valley fever virus NSs gene are alleviated in cultured cells by expressed antiviral short hairpin RNAs","volume":"17","author":"Scott","year":"2012","journal-title":"Antivir. Ther."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1128\/JVI.79.1.234-244.2005","article-title":"La Crosse virus nonstructural protein NSs counteracts the effects of short interfering RNA","volume":"79","author":"Soldan","year":"2005","journal-title":"J. Virol."},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Hedil, M., and Kormelink, R. (2016). Viral RNA Silencing Suppression: The Enigma of Bunyavirus NSs Proteins. Viruses, 8.","DOI":"10.3390\/v8070208"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s12272-020-01230-5","article-title":"3D-quantitative structure-activity relationship and antiviral effects of curcumin derivatives as potent inhibitors of influenza H1N1 neuraminidase","volume":"43","author":"Lai","year":"2020","journal-title":"Arch. Pharm. Res."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nsb941","article-title":"The crystal structure of the proprotein processing proteinase furin explains its stringent specificity","volume":"10","author":"Henrich","year":"2003","journal-title":"Nat. Struct. Biol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1743-422X-11-165","article-title":"Entecavir combined with furin inhibitor simultaneously reduces hepatitis B virus replication and e antigen secretion","volume":"11","author":"Yang","year":"2014","journal-title":"Virol. J."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1128\/JVI.01697-09","article-title":"Targeting the proteolytic processing of the viral glycoprotein precursor is a promising novel antiviral strategy against arenaviruses","volume":"84","author":"Rojek","year":"2010","journal-title":"J. Virol."}],"container-title":["Tropical Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2414-6366\/9\/9\/205\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:51:22Z","timestamp":1760111482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2414-6366\/9\/9\/205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,7]]},"references-count":198,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["tropicalmed9090205"],"URL":"https:\/\/doi.org\/10.3390\/tropicalmed9090205","relation":{},"ISSN":["2414-6366"],"issn-type":[{"value":"2414-6366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,7]]}}}